Metabolic Imaging Services for Global Clinical Trials

Leading Endocrine & Metabolic Imaging CRO

Board-certified radiologists and endocrinologists demonstrating extensive clinical trial experience with complex CT, MRI and DXA assessments (Bone Mineral Density and Total Body Composition)
In-house, registered CT, MRI and DXA technologists who maintain a widespread knowledge in qualifying sites with customized & advanced data and acquisition protocols
Integrative team of technologists, physicians, and medical physicists collectively possessing years of experience with imaging studies, that utilize the CT, MRI and DXA modalities, and their respective analysis and quality control checks
Imaging project managers that specialize in managing imaging trials utilizing these modalities, designing and testing novel phantoms specifically for hepatic fat fraction assessment in MR Imaging
Learn more about our endocrine and metabolic experience

Streamlined Process

Standardization of CT, MRI and DXA image acquisition protocols across global sites
Imaging Review Charter
24/7 global site management
Rigorous quality control and validation process
Abide by Metrics Champion Consortium (MCC)

Integrated Technology

Validated analytical workstations dedicated to CT/MR/DXA data analysis
Seamless integration with other study-related services such as IVRS (ClinTrak^®)
Cloud-based image transmission system with zero local IT footprint (ClinTrak Imaging)

Expert Quality

SOP-driven processes
CFR Part 11 compliant and fully-validated imaging system for clinical trials
Dedicated imaging QA officers

Modalities

Sample Specialties

Response Criteria

Modalities

Computed Tomography (CT)
Magnetic Resonance Elastography (MRE)
Magnetic Resonance Imaging (MRI)
Dual-Energy X-Ray Absorptiometry (DXA)
Cardiac Safety: ECG, Holter TQT
Ambulatory Blood Pressure

Sample Specialties

Hyperlipidemia
Nonalcoholic Steatohepatitis (NASH)
Rare Endocrine Disorders
Diabetes
Obesity
Chronic Kidney Disease
Acromegaly

Response Criteria

Medpace Core Laboratories provide imaging analysis for metabolic disorders such as diabetes, obesity, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Our metabolic imaging endpoint measurements include hepatic fat fraction hepatic fibrosis, bone mineral density, and total body composition. Our cardiac safety solutions for metabolic disorders include TQT Studies, ambulatory ECG monitoring and ambulatory blood pressure monitoring.